Skip to main content
Caplight Logo









Inito

Inito

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.inito.com/

Last Round

Series B

Dec 11, 2025

Total Funding Raised

$44.65M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Inito is a medical technology company that develops at-home diagnostic testing devices, including a smartphone-connected fertility monitor that measures key reproductive hormones.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, D2C Brands, Subscription Commerce, Healthcare Analytics

Business Model

B2C

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

fertility trackerovulation monitorhormone trackingat-home fertility testfemtechquantitative hormone testingfertility appDTC healthhealth IoTcomputer vision diagnosticscycle trackingmedical devicesubscription commerce

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inito Comparables

Compare Inito with similar companies based on industry and business-model similarity.

Inito comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mira
92%
Premom
86%
Proov
85%

Inito Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 11, 2025
Series ANov 16, 2023
SeedMar 1, 2019
AngelMay 31, 2018

Key People

Founding team and executive leadership

Varun AV

Cofounder and CTO

Founding Team

Aayush Rai

Co-Founder & CEO

Founding Team

Inito Investors

Notable investors and investment history

Inito investors
InvestorRounds
Bertelsmann InvestmentsSeries B
IKP Knowledge ParkSeed
Fireside VenturesSeries A, Series B
Y CombinatorSeries B, Seed
Rathi VenturesAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 9, 2026

    Launched the InSight Wireless Reader, a Wi-Fi enabled fertility hormone reader.

  • Dec 11, 2025

    $29M round raised

Inito Filings

Explore SEC and related filing metadata, where available.

Inito filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Inito's valuation, stock price, and market status.

Is Inito a public or private company?

Inito is a private company.

What is the current stock price of Inito?

Inito is a private company with no public stock price. No recent secondary market data is available.

How much is Inito worth (valuation)?

Valuation information for Inito is not publicly available.

Can I buy Inito stock?

Inito shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Inito's last funding round?

Inito's most recent funding round was Series B on December 11, 2025.

Who are the main investors in Inito?

Key investors in Inito include Bertelsmann Investments, Fireside Ventures, Y Combinator.

Will Inito IPO soon?

No public IPO plans have been announced for Inito.

How can I track Inito secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Inito's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range211
Year Founded2015
Last FundingDec 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?